Short Interest in Pulmatrix, Inc. (NASDAQ:PULM) Increases By 27.8%

Pulmatrix, Inc. (NASDAQ:PULM) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 74,900 shares, an increase of 27.8% from the November 30th total of 58,600 shares. Based on an average daily volume of 453,600 shares, the short-interest ratio is presently 0.2 days. Currently, 2.1% of the company’s shares are sold short.

Pulmatrix Stock Performance

PULM stock traded up $0.12 during mid-day trading on Tuesday, reaching $6.98. 31,095 shares of the stock traded hands, compared to its average volume of 127,981. The business has a 50-day moving average price of $4.78 and a two-hundred day moving average price of $3.03. The stock has a market capitalization of $25.49 million, a PE ratio of -2.64 and a beta of 1.53. Pulmatrix has a one year low of $1.55 and a one year high of $8.44.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Pulmatrix in a research report on Saturday. They set a “hold” rating on the stock.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.